These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 20465573)
21. In vitro induction of CD8 expression on thymic pre-T cells. I. Transforming growth factor-beta and tumor necrosis factor-alpha induce CD8 expression on CD8- thymic subsets including the CD25+CD3-CD4-CD8- pre-T cell subset. Suda T; Zlotnik A J Immunol; 1992 Mar; 148(6):1737-45. PubMed ID: 1347307 [TBL] [Abstract][Full Text] [Related]
22. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART. Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058 [TBL] [Abstract][Full Text] [Related]
23. Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets. Li H; Wang W; Wang G; Hou Y; Xu F; Liu R; Wang F; Xue J; Hu T; Luan X Cytotherapy; 2015 Nov; 17(11):1560-71. PubMed ID: 26432559 [TBL] [Abstract][Full Text] [Related]
24. Regulatory T cells and IL-17A levels in noninfectious uveitis. Guedes MCE; Arroz MJ; Martins C; Angelo-Dias M; Proença RD; Borrego LM Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1269-1278. PubMed ID: 32200408 [TBL] [Abstract][Full Text] [Related]
25. Cytokine profile and lymphocyte subsets in type 2 diabetes. Francisco CO; Catai AM; Moura-Tonello SC; Arruda LC; Lopes SL; Benze BG; Del Vale AM; Malmegrim KC; Leal AM Braz J Med Biol Res; 2016; 49(4):e5062. PubMed ID: 27007651 [TBL] [Abstract][Full Text] [Related]
26. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613 [TBL] [Abstract][Full Text] [Related]
27. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells. Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171 [TBL] [Abstract][Full Text] [Related]
28. Determination of a CD4 Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682 [TBL] [Abstract][Full Text] [Related]
29. STAT3 promotes bone fracture healing by enhancing the FOXP3 expression and the suppressive function of regulatory T cells. Sun G; Wang Z; Ti Y; Wang Y; Wang J; Zhao J; Qian H APMIS; 2017 Aug; 125(8):752-760. PubMed ID: 28493494 [TBL] [Abstract][Full Text] [Related]
30. Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+ T-cells in patients with autoimmune diseases affecting the central nervous system. Vudattu NK; Kuhlmann-Berenzon S; Khademi M; Seyfert V; Olsson T; Maeurer MJ PLoS One; 2009 Aug; 4(8):e6534. PubMed ID: 19657390 [TBL] [Abstract][Full Text] [Related]
31. Tim3 Sun H; Gao W; Pan W; Zhang Q; Wang G; Feng D; Geng X; Yan X; Li S Inflammation; 2017 Aug; 40(4):1342-1350. PubMed ID: 28478516 [TBL] [Abstract][Full Text] [Related]
32. Regulatory T cell levels and cytokine production in active non-infectious uveitis: in-vitro effects of pharmacological treatment. Molins B; Mesquida M; Lee RW; Llorenç V; Pelegrín L; Adán A Clin Exp Immunol; 2015 Mar; 179(3):529-38. PubMed ID: 25354724 [TBL] [Abstract][Full Text] [Related]
33. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis. Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721 [TBL] [Abstract][Full Text] [Related]
34. CD4(+) CD25(+) FoxP3(+) T regulatory cells in subjects responsive or unresponsive to hepatitis B vaccination. Li J; Tan D; Liu H; Li K Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1046-51. PubMed ID: 22169715 [TBL] [Abstract][Full Text] [Related]
35. Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cells. Gansuvd B; Hubbard WJ; Hutchings A; Thomas FT; Goodwin J; Wilson SB; Exley MA; Thomas JM J Immunol; 2003 Sep; 171(6):2904-11. PubMed ID: 12960313 [TBL] [Abstract][Full Text] [Related]
36. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation. Wang H; Daniel V; Sadeghi M; Opelz G Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052 [TBL] [Abstract][Full Text] [Related]
37. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. Abraham M; Karni A; Dembinsky A; Miller A; Gandhi R; Anderson D; Weiner HL J Autoimmun; 2008; 30(1-2):21-8. PubMed ID: 18191540 [TBL] [Abstract][Full Text] [Related]
38. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy. Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993 [TBL] [Abstract][Full Text] [Related]
39. CD8αα Expression Marks Terminally Differentiated Human CD8+ T Cells Expanded in Chronic Viral Infection. Walker LJ; Marrinan E; Muenchhoff M; Ferguson J; Kloverpris H; Cheroutre H; Barnes E; Goulder P; Klenerman P Front Immunol; 2013; 4():223. PubMed ID: 23964274 [TBL] [Abstract][Full Text] [Related]
40. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma. Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]